Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II.

导出 OA

翻译打印收藏纠错

作者： Raban V,Jeger ^[1] ; Matthias,Pfisterer ^[1] ; Deborah R,Vogt ^[1] ; Søren,Galatius ^[2] ; Ulrik,Abildgaard ^[2] ; Christoph,Naber ^[3] ; Hannes,Alber ^[4] ; Franz,Eberli ^[5] ; David J,Kurz ^[5] ; Giovanni,Pedrazzini ^[6] ; André,Vuilliomenet ^[7] ; Daniel,Weilenmann ^[8] ; Hans,Rickli ^[8] ; Kim Wadt,Hansen ^[1] ; Peter,Rickenbacher ^[9] ; David,Conen ^[1] ; Christian,Müller ^[10] ; Stefan,Osswald ^[1] ; Nicole,Gilgen ^[1] ; Christoph,Kaiser ^[1]

作者单位： Cardiology, University Hospital Basel, University Basel, Basel, Switzerland. ^[1] Cardiology, Gentofte University Hospital Copenhagen, Hellerup, Denmark. ^[2] Cardiology, Elisabeth-Krankenhaus, Essen, Germany. ^[3] Cardiology, University Hospital Innsbruck and Klinikum Klagenfurt am Wörthersee, Innsbruck and Klagenfurt am Wörthersee, Austria. ^[4] Cardiology, Triemli Hospital, Zürich, Switzerland. ^[5] Cardiology, Cardiocentro, Lugano, Switzerland. ^[6] Cardiology, State Hospital, Aarau, Switzerland. ^[7] Cardiology, State Hospital, St. Gallen, Switzerland. ^[8] Cardiology, State Hospital, Bruderholz, Switzerland. ^[9] Population Health Research Institute, McMaster University, Hamilton ON, Canada. ^[10]